In a historic milestone for Bharat’s assistive technology sector, the All India Institute of Medical Sciences (AIIMS) Bibinagar and the Defence Research and Development Laboratory (DRDL), under the Defence Research and Development Organisation (DRDO), have jointly unveiled the ADIDOC Foot Prosthesis—the country’s first indigenously developed high-performance carbon fibre foot for lower limb amputees.
The unveiling ceremony took place on July 14, 2025, led by Dr. G A Srinivasa Murthy, Director of DRDL-DRDO, and Dr. Ahanthem Santa Singh, Executive Director of AIIMS Bibinagar, Telangana, with virtual participation by Praveen Kumar, CMD of the Artificial Limbs Manufacturing Corporation of India (ALIMCO).
Historic Milestone for #MakeInIndia! 🇮🇳
AIIMS Bibinagar & DRDL-DRDO unveil ADIDOC Foot Prosthesis – India’s first indigenously developed high-performance carbon fibre foot for lower limb amputees
✅ Affordable (Expected cost < ₹20,000)
✅ Biomechanically validated (Up to 125 kg pic.twitter.com/6Wnf3n2czB— AIIMS Bibinagar (@AiimsBibinagar) July 15, 2025
Designed to empower lower limb amputees, this prosthesis combines affordability, accessibility, and high performance, making it a game-changer in assistive devices.
Key Features of the ADIDOC Foot Prosthesis
- Affordable Pricing: Expected to cost less than Rs 20,000, ensuring accessibility for a wider population.
- Biomechanically Validated: Engineered to support loads up to 125 kg with a sufficient factor of safety.
- High Performance for Active Users: Tailored for K3-level active users, enabling dynamic and agile movement.
- Three Variants: Offers customized fit options to meet diverse user needs.
DRDL, DRDO and AIIMS Bibinagar has jointly developed a first “Made in India” cost effective high profile advanced Carbon Fibre Foot Prosthesis-ADIDOC (AIIMS Bibinagar – DRDL, DRDO Indigenously Developed Optimised Carbon Foot Prosthesis).
The ADIDOC Foot is an indigenously… pic.twitter.com/hVulExZkgk
— DRDO (@DRDO_India) July 15, 2025
The ADIDOC Foot is a groundbreaking achievement under the Make in India and Atmanirbhar Bharat initiatives, showcasing India’s strides toward self-reliance in advanced medical technologies.
Comments